See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
NFL
Baseball
Vatican
Motorsports
Real Madrid
Social Media
South America
Tennis
Golf
Catholic Church
Soccer
Published • loading... • Updated

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis

Summary by Laotian Times
VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) in treating NIAU Clinically meaningful reductions in inflammation compared to baseline observed as early as Day 3 Strong safety profile with no substantial treatment-related adverse events reported WENZHOU, China, April […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

All
Left
Center
Right
modernretina.commodernretina.com

Positive topline results from phase 2 VVN461 trial for non-infectious anterior uveitis

VivaVision Biotech reveals promising phase 2 trial results for VVN461, a new treatment for Non-Infectious Anterior Uveitis, showcasing safety and efficacy.

Read Full Article
hcplive.comhcplive.com

VVN461 Trial Topline Results Announced for Non-Infectious Anterior Uveitis

Parent company VivaVision plans to request a type C meeting with the US Food and Drug Administration.

Read Full Article
Laotian TimesLaotian Times

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Non-Infectious Anterior Uveitis

VVN461, a dual JAK1/TYK2 inhibitor as a non-steroidal anti-inflammatory agent, has met primary endpoints, demonstrating non-inferior efficacy compared to the standard therapy, prednisolone acetate (PA) in treating NIAU Clinically meaningful reductions in inflammation compared to baseline observed as early as Day 3 Strong safety profile with no substantial treatment-related adverse events reported WENZHOU, China, April […]

Read Full Article
ophthalmologytimes.comophthalmologytimes.com

Diagnosis and disease evolution of uveitis: A 10-year look back

ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

ophthalmologytimes.com broke the news in on Thursday, April 24, 2025.
Sources are mostly out of (0)

Similar News Topics

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal